Join Abbott at AACC


July 26-28, 2022 | Chicago, IL
*Be sure to select the "Expo Only" checkbox within the Registration Options section.

ACHIEVE MEASURABLY BETTER HEALTHCARE PERFORMANCE WITH OUR PERSONALIZED SOLUTIONS

Abbott’s booth will bring you new ways to achieve measurably better healthcare performance with our personalized core diagnostics solutions consisting of Resourceful Advocates, Harmonized Systems and Intelligent Insights.

VP_Icons_No Text_300x200-Resourceful Advocates.png
 

Resourceful
Advocates

 

VP_Icons_No Text_300x200-Harmonized Systems.png
 

Harmonized
Systems

VP_Icons_No Text_300x200-Intelligent Insights.png
 

Intelligent
Insights

You’re invited to an exciting experience celebrating 50 years of diagnostic innovation that helps you enhance patient care now and into the future.

automation-glp-systems-1457x488.jpg

 

the future of automation: glp systems

As your lab is adapting to the demands of increased testing volumes, enhanced assay performance, and turnaround expectations, it's important to have a flexible automation option.

With your lab in mind, the GLP Systems is designed to provide:

  1. Freedom to change. Easily modify your track for future changes and maximize floor space while transforming your laboratory from 2D to 3D.
  2. Simplicity through intuitive design. Minimize track implementation time, receive more efficient service and training.
  3. Excellence in performance. Maximize uptime with infinite redundancy, optimize workflow, and decrease turnaround time system can meet your laboratory’s needs.

 

Demonstrations & Workshops

Experience demonstrations to innovate your lab

This year, experience one-on-one or group demonstrations to learn about our latest offerings. During the product demonstrations, you can explore Abbott's next generation of Alinity systems, designed to simplify diagnostics and help deliver results. Demonstrations for GLP systems Track*, AlinIQ Digital Health Solutions, Hematology, Molecular, Diabetes Care and Point of Care are also available.

 

 

Scientific Workshops 

As a leader in diagnostic innovation for 50 years, hear how we continue to evolve during our three scientific workshops. 

 

Ensuring Accurate Lab Results in the Era of Biotin Interference and the COVID-19 Pandemic 
Tuesday, July 26  |   7 AM   |  MARRIOT MARQUIS CHICAGO, GRAND HORIZON BALLROOM A/B – 4TH FLOOR

 

Blood-based Biomarkers for Traumatic Brain Injury (TBI): New findings from the Transforming Research and Clinical Knowledge (TRACK) in TBI and the Concussion Assessment, Research and Education (CARE) Consortium Multi Center Teams 
Wednesday, JULY 27  |   7 AM   |  MARRIOT MARQUIS CHICAGO, GRAND HORIZON BALLROOM A/B – 4TH FLOOR

 

Matching COVID-19 Testing to Patient Needs in the New Phase of the Epidemic
WEDNESDAY, JULY 27  |   3:30 pm   |  MCCORMICK PLACE, SOUTH HALL, THEATER 1

 

Sign Up for Demos and Workshops

 


 

med talks 

Join us in our booth for innovation in action with educational MED Talks, a comprehensive series of trending topics led by industry experts in partnership with top researchers, collaborators, and key opinion leaders.

 

Topic Speaker/moderator time
TUESDAY, JULY 26
 Biomarkers of Brain Injury; Early Experiences to Advance Care

Moderator: Dr. Chris Davlantes
Emergency Medicine Physician Senior Director, Global Medical Affairs Point of Care at Abbott

Speaker: Dr. Carmen Gherasim 
Clinical Assistant Professor – Department of Pathology, University of Michigan

10:30am
Making the Transition to HsTnI: Critical Challenges and Solutions

Moderator: Dr. Gillian Murtagh
Associate Medical Director, Medical Affairs - Core Diagnostics at Abbott

Speaker: Dr. Chris Farnsworth
Co-Medical Director of Clinical Chemistry and Medical Director of Point-of-Care testing, Barnes Jewish Hospital and Washington University

Speaker: Dr. Jon Gronbach
Laboratory Director, Holyoke Medical Center

11:30am
The Evolution of Artificial Intelligence and Machine Learning in Laboratory Medicine. Where do we go from here?

Moderator: Dr. Randal Schneider
Director Medical & Scientific Affairs - Core Diagnostics at Abbott

Speaker: Dr. Daniel Herman
Assistant Professor of Pathology and Laboratory Medicine - University of Pennsylvania Perelman School of Medicine
Director of Endocrine Laboratory, Hospital of the University of Pennsylvania

Speaker: Dr. Thomas Durant
Assistant Professor, Department of Laboratory Medicine
Medical Director of Laboratory Information Technology
Yale Univertsity School of Medicine

12:30pm
From R&D to Operational Excellence: New advancements in Molecular Diagnostics

Moderator: Dr. Klara Abravaya, DVP, R&D Abbott
Divisional Vice President Research & Development at Molecular Diagnostics, Abbott

Speaker: Michael Flores,
Director Systems R&D – Systems Research & Development at Molecular Diagnostics, Abbott

2:00pm
Traumatic Brain Injury : Fact or Fiction?

Moderator: Dr. Chris Davlantes
Emergency Medicine Physician Senior Director, Global Medical Affairs Point of Care at Abbott

Moderator: Dr. Beth McQuiston
Medical Director - Core Diagnostics at Abbott

Speaker: Angela Lauster
Senior Administrative Laboratory Director, Tampa General Hospital

3:00pm

WEDNESDAY, JULY 27

The Forefront of Innovation Using Biomarkers of Brain Injury

Moderator: Dr. Chris Davlantes
Emergency Medicine Physician Senior Director, Global Medical Affairs Point of Care at Abbott

Speaker: Angela Lauster
Senior Administrative Laboratory Director Tampa General Hospital

10:30am
How the Abbott Pandemic Defense Coalition Stops Viruses in Their Tracks to Prevent The Next Pandemic

Moderator: Dr. Alexander Carterson
Divisional Vice President Medical, Scientific & Clinical Affairs & HEOR - Core Diagnostics at Abbott

Speaker: Dr. Mary Rodgers
Principal Research Scientist Infectious Disease Research - Core Diagnostics at Abbott

 11:30am
 From HBsAg to HIV: 50 Years of Innovation

Moderator: Dr. Alexander Carterson
Divisional Vice President Medical, Scientific & Clinical Affairs & HEOR - Core Diagnostics at Abbott

Speaker: Dr. John Hackett
Divisional Vice President Applied Research & Technology Sr. Research Fellow, Volwiler Society - Core Diagnostics at Abbott

Speaker: Dr. Oliver Laeyendecker
Epidemiologist, IHSS/LIR/NIAID/NIH Associate Professor, Infectious Diseases, SOM/JHU Associate Professor, Epidemiology, JHSPH

 12:30pm

New Innovations and Benefits through Optimized Quality Control

Moderator: Dr. Ramani Wonderling
Associate Director, U.S. Scientific Affairs - Core Diagnostics at Abbott

Speaker: Kevin Williams, Lab Supervisor
Chemistry and Urinalysis, VA Health Care System, Columbia, South Carolina

 2:00pm
Cutting-edge experiences: Early feedback from i-STAT TBI Plasma Users

Moderator: Dr. Chris Davlantes
Emergency Medicine Physician Senior Director, Global Medical Affairs Point of Care at Abbott

Speaker: Angela Lauster
Senior Administrative Laboratory Director Tampa General Hospital

Speaker: Carmen Gherasim,
Clinical Assistant Professor – Department of Pathology, University of Michigan

3:00pm

view 25+ posters and hear from each author 

Posters can be viewed from 9:30 a.m. – 5 p.m. Authors will be at available for discussion next to their posters from 1:30 – 2:30 p.m. on Tuesday, July 26 and Wednesday, July 27.

 

poster title Presenting author poster number
TUESDAY, JULY 26     
Analytical Performance Assessment of a Newly Formulated, IFCC traceable Alkaline Phosphatase Assay for Abbott’s ARCHITECT c and Alinity c Systems J. Sheldon A-076
Development of Exploratory Algorithms using Plasma Biomarkers on ARCHITECT i2000 and c8000 Platforms, Demographic, and Radiomic Data to Aid in Risk of Malignancy Prediction of Indeterminate Pulmonary Nodules N. Jeanblanc A-041
Research Use Only (RUO) IgG1 and IgG2 Subclass Assays on the Abbott Alinity c Clinical Chemistry Analyzer  N. Jeanblanc  A-042
Improved accuracy across the analytical measuring range for the newly formulated Calcium assay on Abbott’s ARCHITECT and Alinity c Systems  S. Syed A-081 
Stability Performance Impact of Clinical Chemistry Enzyme Assays Prepared in Stainless Steel Containers  S. Syed  A-082
Improved Analytical Measuring Interval and Hemoglobin performance for New Investigational Use Assay (IUO) Triglyceride Assay on the Abbott’s ARCHITECT and Alinity c Systems  S. Ali  A-004
Improved hemoglobin interference performance on newly formulated Cholesterol assay for Abbott’s ARCHITECT and Alinity c systems.  H. Soni  A-078
Pre-analytical Characterization of Nasal and Nasopharyngeal Specimen CoV2 Antigen Stability in Transport Media  C. Jacobson  A-040
Reagent Lot Consistency of Three Common Cardiac Markers on Alinity i  K. Johnson  A-044
Evaluation of Reagent Lot-to-Lot Performnace of Alinity i Tumor Marker Assays  K. Johnson A-043 
A Pre-treatment free and Highly Selective Chromogenic Research Use Only (RUO) assay for Zinc deficiency on the Abbott Alinity c System  L. Ruvuna  A-071
Pediatric reference interval verification for special chemistry, immunoassay, and cancer markers on the Abbott Alinity ci system  M.K. Bohn  A-242
Serological Antibody Response to SARS-CoV-2 Vaccination in a Large Cohort of Canadian Children, Adolescents, and Adults  M.K. Bohn A-244 
WEDNESDAY, JULY 27    
Development of the hCG+β immunoassay standardized to the 6th WHO International Standard for hCG for Abbott’s Alinity i® analyzer  K. Holman  B-038
Analytical performance evaluation of the next generation Clinical Chemistry assays on the ARCHITECT system  H. Ren  B-067
Longitudinal post immunisation serology of covid 19 using the Abbott Alinity SARS-CoV-2 IgG II quantitative assay  I. Piec  B-227
Measurement of HbA1c in Packed Red Blood Cells using the Abbott Hemoglobin A1c assay  P. Henriques  B-037
Evaluation of Hemoglobin variants in the Abbott Alinity c HbA1c assay  J. Nichols  B-171
Development of a Prototype SARS-CoV-2 Antigen ARCHITECT Automated Immunoassay  P. Hemken  B-199
Performance Evaluation of Abbott Neuron-Specific Enolase (NSE) Assay on Alinity and ARCHITECT Systems  C. Chen  B-015
Multi-center Performance Evaluation of the HSV-1 IgG and HSV-2 IgG Assays* on the ARCHITECT i2000SR System  A. Martinez  B-221
Evaluation of the ARCHITECT Toxo IgG and Alinity i Toxo IgG Assays for the US Market  W. Krack  B-213
Comparison of Two NT-ProBNP assays  D. Daghfal  B-018
18-Month Trends of SARS-CoV-2 Anti-Spike IgG Antibodies Among Healthcare Workers  Y. Kataria  TBA
SARS-CoV-2 Seroprevalence in Rhode Island Pregnancies in Early 2020  R. Schneider  B-236
First pass efficiency of Alinity hq compared to Sysmex XN-10  S. Silvia  B-176
Morphological flagging of Alinity hq compared with Siemens Advia 2120 in a tertiary care pediatric hospital  S. Silvia  B-177

 

REGISTER EARLY FOR COMPLIMENTARY ACCESS FROM AACC TO THE LAB EXPO.


 

Explore 


knowledge-center-learning-guide_200x300.jpg

Learning Guides

Build key laboratory competencies and explore topics from various disciplines with our learning guides.

Visit the Learning guides

knowledge-center-crosslink_300x200.jpg

Knowledge Center

Find the latest information in laboratory science, therapeutic areas and Abbott innovation.

Visit Knowledge Center  

tvo-webinar-efficiency-image-300x200.jpg

Webinar: Total Value of Ownership

Watch the webinar to hear from experts how you can realize the value within and beyond your laboratory walls with a TVO approach. 

Watch The Webinar 

You are about to exit the Abbott family of websites for a 3rd party website

Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.

Do you wish to continue and exit this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

You are about to enter an Abbott country or region specific website.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.

Do you wish to continue and enter this website?

Yes No

DO YOU WISH TO CONTINUE AND EXIT THE CORE LABORATORY WEBSITE?

Content is not under the control of corelaboratory.abbott.

Yes No